Healthcare
•3755 stocks
•
Total Market Cap: Loading...
Price Performance Heatmap
5Y Price (Market Cap Weighted)
All Stocks (3755)
| Company | Market Cap | Price |
|---|---|---|
|
ZYXI
Zynex, Inc.
Directly manufactures medical devices and biometrics used for patient monitoring and non-opioid pain management.
|
$3.11M |
$0.13
+2.22%
|
|
VERO
Venus Concept Inc.
Venus Concept produces medical aesthetic devices and robotic systems (Venus platforms, ARTAS iX) and related medical devices.
|
$3.10M |
$2.23
+33.23%
|
|
AMIX
Autonomix Medical, Inc. Common Stock
Core platform is a catheter-based Neuromodulation Device designed to sense and ablate peripheral nerves.
|
$3.10M |
$0.63
+4.38%
|
|
BZYR
Burzynski Research Institute, Inc.
Company focuses on oncology therapeutics in biotech R&D.
|
$3.02M |
$0.02
|
|
PHGE
BiomX Inc.
BiomX leverages a drug delivery platform (BOLT) to rapidly assemble phage cocktails and targeted therapies.
|
$3.02M |
$2.16
|
|
MYNZ
Mainz Biomed B.V.
PancAlert is a blood-based diagnostic test using biomarker panels (liquid biopsy) to detect pancreatic cancer, fitting the Liquid Biopsy investable theme.
|
$2.92M |
$1.20
-4.76%
|
|
RMSL
REMSleep Holdings, Inc.
RMSL designs and manufactures CPAP-based respiratory medical devices (DeltaWave), directly aligning with 'Medical Devices & Biometrics'.
|
$2.75M |
$0.00
|
|
HCWB
HCW Biologics Inc.
HCWB's lead programs target oncology through novel immunotherapies, aligning with Biotech - Oncology.
|
$2.69M |
$1.22
-2.80%
|
|
XWEL
XWELL, Inc.
XWEL's XpresTest program represents laboratory testing and advisory services, anchored by CDC collaborations and pathogen surveillance.
|
$2.63M |
$0.45
-2.23%
|
|
BTCY
Biotricity, Inc.
Core cardiology device portfolio including 3-channel ECG monitoring platforms (Bioflux/Biocore/Biocore Pro).
|
$2.61M |
$0.30
|
|
JAGX
Jaguar Health, Inc.
Jaguar Health focuses on crofelemer-based therapies delivered orally, aligning with the Oral Small Molecule Therapeutics category.
|
$2.54M |
$1.18
+3.98%
|
|
STSS
Sharps Technology, Inc.
Core product category: Safety syringes (SafeGard/Sologard) with passive safety features.
|
$2.54M |
$2.56
+3.43%
|
|
VTAK
Catheter Precision, Inc.
VTAK's VIVO System is a cardiology-focused medical device for non-invasive 3D mapping, aligning with Cardiology Devices.
|
$2.43M |
$2.15
-3.15%
|
|
MHUA
Meihua International Medical Technologies Co., Ltd.
Meihua International Medical Technologies' core business is the manufacturing and sale of disposable medical device consumables.
|
$2.43M |
$7.62
+0.13%
|
|
CRVW
CareView Communications, Inc.
CareView's core offering is patient monitoring via video-based systems, including SitterView and TeleMedView components.
|
$2.37M |
$0.02
|
|
CANF
Can-Fite BioPharma Ltd.
Company focuses on orally bioavailable small molecule therapeutics targeting A3AR, including Piclidenoson and Namodenoson.
|
$2.34M |
$4.37
-7.32%
|
|
CARM
Carisma Therapeutics, Inc.
CAR-Macrophage platform is a cell-therapy technology, directly representing Carisma's core product category.
|
$2.33M |
$0.15
+196.92%
|
|
BIOE
Bio Essence Corporation
Provides outsourced contract manufacturing (OEM) services for health-related products.
|
$2.22M |
$0.06
|
|
CLSD
Clearside Biomedical, Inc.
Clearside's core offering is a drug delivery platform enabling suprachoroidal (eye) delivery and extended-release formulations.
|
$2.15M |
$0.43
+4.90%
|
|
AAGH
America Great Health
Focus on peptide/protein therapeutics as a core research and therapeutic development area.
|
$2.12M |
$0.00
|
|
YBGJ
Yubo International Biotech Limited
Endometrial stem cell research and potential cell therapies (core biotech focus).
|
$2.11M |
$0.01
|
|
BICX
BioCorRx Inc.
BioCorRx is actively commercializing Lucemyra, an FDA-approved oral small molecule therapeutic for opioid withdrawal, expanding direct product sales.
|
$2.10M |
$0.29
|
|
SHPH
Shuttle Pharmaceuticals Holdings, Inc.
Company is a oncology-focused biotech developing radiation sensitizers and HDAC inhibitor therapeutics, with lead assets in Phase 2/preclinical stages.
|
$1.98M |
$1.79
-2.97%
|
|
EVTV
Envirotech Vehicles, Inc.
Medical Device Consumables: Medical supplies segment with related-party sales and cost-plus pricing indicating consumable offerings.
|
$1.77M |
$0.53
+6.55%
|
|
ELAB
PMGC Holdings Inc.
Contract Research Organizations (CRO)-like R&D capabilities through PMGC Research Inc. for biotech development.
|
$1.63M |
$3.35
-13.12%
|
|
APVO
Aptevo Therapeutics Inc.
APVO is a oncology-focused biotech developing novel immunotherapies, including mipletamig and other pipelines targeting cancer.
|
$1.63M |
$9.03
+1.35%
|
|
REVB
Revelation Biosciences, Inc.
Core product focus on modulating innate immunity using the Gemini platform, aligning with Immunology Therapeutics.
|
$1.55M |
$0.91
+0.13%
|
|
ENVB
Enveric Biosciences, Inc.
Enveric is focused on neuropsychiatric drug development with a lead program targeting neuroplasticity-based therapies.
|
$1.45M |
$5.21
-2.71%
|
|
GRTX
Galera Therapeutics, Inc.
Company directly develops oncology therapeutics, including its NOS pan-inhibitor and SOD mimetics for cancer indications.
|
$1.31M |
$0.02
|
|
VYST
Vystar Corporation
RxAir medical-grade air purification devices and FDA-cleared units position the company in medical devices and biometrics.
|
$1.26M |
$0.06
|
Showing page 37 of 38 (3755 total stocks)
Loading company comparison...
Loading industry trends...
Loading research report...
